2Hol FA, Geurds MP, Chatkupt Set al. PAX genes and human neural tube defects: an amino acid substitution in PAX 1 in a patient with spina bifida. J Med Genet, 1996, 33 (8) : 655.
3Chatkupt S, Hol FA, Shugart YY et al. Absence of linkage between familial neural tube defects and PAX3 gene. J Med Genet, 1995, 32(3) : 200.
4Joosten PH, Toetoel M, Mariman EC et al. Promoter haplotype combinations of the platelet - derived growth factor - receptor gene predispose to human neural tube defects. Nat Genet, 2001, 27 (2) : 215.
5Joosten PH, Toepoel M, Van Oosterhout D et al. A regulating element essential for PDGFRA transcription is recognized by neural tube defectassociated PRX homeobox transcription tactors. Biochim Biophys Acta,2002, 1 588 (3): 254.
6Zhu H, Wicker N J, Volcik K et al. Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects. Mol Genet Metab, 2004, 81 ( 2 ) : 127.
7Homberger A, Linnebank M, Winter C et al. Genomic structure and transcript variants of the human MTHFR gene. Eur J Hum Genet,2000, 8:725.
8Chen LH, Liu ML, Hwang Hy et al. Human methionine synthase: cDNA cloning, gene localization, and expression. J Biol Chem, 1997,272:3628.
9Wilson A, Platt R, Wu Q. A common variant in methionine synthase reductasw combined with low cobalamin ( Vitmin Bt2 ) increases risk for spina bifida. Mol Genet Metab, 1999, 67:317.
10Relton CL, Wilding CS, Pearce MS et al. Gene - gene interaction in folate - related genes and risk of neural tube defects in a UK population. J Med Genet, 2004, 41 (4) : 256.
